| CSZIX | PAREX | CSZIX / PAREX | |
| Total Expense Ratio | 0.75 | 1.19 | 63% |
| Annual Report Gross Expense Ratio | 0.75 | 1.24 | 60% |
| Fund Existence | 12 years | 22 years | - |
| Gain YTD | 16.252 | 15.211 | 107% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.61B | 669M | 1,436% |
| Annual Yield % from dividends | 2.69 | 2.11 | 128% |
| Returns for 1 year | 16.86 | 12.58 | 134% |
| Returns for 3 years | 35.18 | 5.04 | 698% |
| Returns for 5 years | 12.74 | -32.70 | -39% |
| Returns for 10 years | 64.33 | -49.77 | -129% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RBCIX | 12.35 | 0.09 | +0.73% |
| RBC China Equity I | |||
| MKGCX | 35.24 | 0.18 | +0.51% |
| BlackRock Advantage Global K | |||
| PGINX | 24.22 | 0.10 | +0.41% |
| Impax Global Environmental Markets Instl | |||
| PMVFX | 33.76 | -0.08 | -0.24% |
| PGIM Quant Solutions Mid-Cap Val R4 | |||
| BHSRX | 58.34 | -0.65 | -1.10% |
| BlackRock Health Sciences Opps R | |||